Medication Administration in a School Setting: School Nursing Practice in Massachusetts
What do nurses need to know about medication administration in Massachusetts schools?
Category
  • SHIELD
  • SHIELD DESE Mandated Course
Format
  • Self-study / Enduring
Credits
  • 2.75 ANCC
  • 2.75 Participation
School Health Screenings
♦ NOTE: This course contains specific training in
Category
  • SHIELD
  • SHIELD DESE Mandated Course
Format
  • Self-study / Enduring
Credits
  • 2.50 ANCC
  • 2.50 Participation
Managing your CSHS Budget
COST: $30CREDIT: 2.5 CNE creditsLooking for the FREE (audit) version of this course (PARTICIPATION CREDIT ONLY)? It can be found here.
Category
  • SHIELD CSHS
Format
  • Self-study / Enduring
Credits
  • 2.50 AMA PRA Category 1 Credit™
  • 2.50 ANCC
  • 2.50 Participation
The Essentials of School Nurse Leadership
What key competencies are necessary to be a strong performing leader? What steps can I take to build these skills?
Category
  • SHIELD
Format
  • Self-study / Enduring
Credits
  • 3.50 ANCC
  • 3.50 Participation
Struggling to Breathe: The Patient Journey to Diagnosis and Treatment of Interstitial Lung Disease
This is a 1.25-hour on-demand activity that provides guidance to primary care clinicians who manage care and support for patients with ILDs and their caregivers. The five (5) member faculty is comprised of a primary care physician (PCP), a pulmonologist, an ILD clinical pharmacy specialist, an ILD nurse, and an actual patient with ILD. This multidisciplinary roundtable is delivered as a role-played patient-case through several office visits. The primary care physician interviews an actual ILD patient and consults with the interprofessional team-members on management and best treatment methods. Also included are video vignettes of actual patients to provide the patient's perspective. 
Category
  • Primary Care
Format
  • Self-study / Enduring
Credits
  • 1.00 AAFP Prescribed
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC
  • 1.25 Participation
Overcoming Barriers to Effective Treatment and Enrollment in Clinical Trials for Black and Underserved Patients with Multiple Myeloma - Focus Group Panel Discussion
Multiple myeloma (MM) is one of the most common hematologic malignancies in adults and is the most common hematologic malignancy in Black patients. The incidence of MM in the black population is 2-3 times higher than in white patients however, the vast majority of MM clinical trials are conducted on a predominantly white population, resulting in a lack of data regarding MM treatment in Black patients. Our panel of expert Hematology/Oncology faculty convene a patient focus group-informed interactive video discussion emphasizing the treatment and clinical research disparities among Black and underserved patients. The focus groups were comprised of diverse groups of MM patients currently being treated at Boston Medical Center. This educational program builds off the complementary enduring activity to further address existing knowledge gaps related to the racial disparities which impact MM therapy and clinical trial inclusion; highlight ongoing inequities; and provide guidance so that healthcare clinicians can more effectively and equitably treat patients with MM. This activity dives into the results of the focus groups via a moderated panel discussion of the interprofessional care team.
Category
  • Hematology/Oncology
Format
  • Self-study / Enduring
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC
  • 0.75 Participation
Aging Well with HIV: Care Transitions for Older People Living with HIV
This two-module activity addresses the current state of HIV in th
Category
Format
  • Self-study / Enduring
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 ANCC
  • 2.00 Participation
Supporting LGBTQI Youth
Do you feel prepared to meet the mental health needs of your LGBTQI students?
Category
  • SHIELD
Format
  • Self-study / Enduring
  • Video
Credits
  • 1.75 ANCC
  • 1.75 Participation
Overcoming Barriers to Effective Treatment and Enrollment in Clinical Trials for Black and Underserved Patients with Multiple Myeloma
Multiple myeloma (MM) is one of the most common hematologic malignancies in adults and is the most common hematologic malignancy in black patients. The incidence of MM in the black population is 2-3 times higher than in white patients however, the vast majority of MM clinical trials are conducted on a predominantly white population, resulting in a lack of data regarding MM treatment in black patients. Our panel of expert Hematology/Oncology faculty convened a patient focus group-informed interactive video discussion emphasizing the treatment and clinical research disparities among black and underserved patients. The focus groups were comprised of diverse groups of MM patients currently being treated at Boston Medical Center. The goals of our educational program are to address existing knowledge gaps related to the racial disparities which impact MM therapy and clinical trial inclusion; highlight ongoing inequities; and provide guidance so that healthcare clinicians can more effectively and equitably treat patients with MM.
Category
  • Hematology/Oncology
Format
  • Self-study / Enduring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Experiences of Youth with Behavioral and Emotional Needs in Massachusetts: Stories from the Mental Health Advocacy Program for Kids (MHAP for Kids)
What are the negative impacts of school exclusion on children with mental health challenges and their families? What is the MHAP for Kids Program?
Category
  • SHIELD
Format
  • Self-study / Enduring
Credits
  • 1.00 ANCC
  • 1.00 Participation

Pages